Showing results (481-490 of 504) with videos related to

Sort By:
Pageof 51
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2011
Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 studyBianca G Couto, Regina C dos Santos Goldenberg, Léa M B da Fonseca, et al.
Frontiers in Medicine|February 7, 2022
Prevalence and Clinical Profiling of Dysglycemia and HIV Infection in Persons With Pulmonary Tuberculosis in BrazilMaría B Arriaga, Mariana Araújo-Pereira, Beatriz Barreto-Duarte, et al.
Microorganisms|December 23, 2023
Introduction, Dispersal, and Predominance of SARS-CoV-2 Delta Variant in Rio Grande do Sul, Brazil: A Retrospective AnalysisThaís Regina Y Castro, Bruna C Piccoli, Andressa A Vieira, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potentialDavid R Martinez, Fernando R Moreira, Mark R Zweigart, et al.
Nature Medicine|August 18, 2022
Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2Rachel J Hagey, Menashe Elazar, Edward A Pham, et al.
Cell Reports|November 6, 2024
An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivoNian E Zhou, Su Tang, Xuelin Bian, et al.
Plos One|March 10, 2025
Morbillivirus and coronavirus survey in stranded cetaceans, BrazilSamira Costa-Silva, Carlos Sacristán, Arícia Duarte-Benvenuto, et al.
Science Translational Medicine|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronavirusesDavid R Martinez, Fernando R Moreira, Nicholas J Catanzaro, et al.
Transplantation and Cellular Therapy|June 29, 2026
Comparison of Carmustine-, Lomustine-, and Nitrosourea-free Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Lymphoma (auto-HTC): Results from the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR)Abrahão Elias Hallack Neto, Vanderson Rocha, Eliana Miranda, et al.
Pageof 51